4//SEC Filing
MCNAB JAMES R 4
Accession 0001104659-22-008949
CIK 0000910267other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 3:14 PM ET
Size
5.5 KB
Accession
0001104659-22-008949
Insider Transaction Report
Form 4
MCNAB JAMES R
Director
Transactions
- Other
Common Stock
2022-01-28+51,021→ 51,021 total(indirect: By JT Pharma)
Holdings
- 1,669
Common Stock
Footnotes (1)
- [F1]Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001190126
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 3:14 PM ET
- Size
- 5.5 KB